USD 294.8 million
Anti-Venom Market Size, Share, Growth Analysis, By Type(Polyvalent anti-venom and monovalent anti-venom), By Species(Snakes, scorpions, spiders, and others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35J2097 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
62
|Figures:
75
Anti-Venom Market Insights
Anti-Venom Market size was valued at USD 317.50 million in 2022 and is poised to grow from USD 341.94 million in 2023 to USD 619 million by 2031, at a CAGR of 7.7% during the forecast period (2024-2031).
The global anti-venom market has witnessed significant growth in recent years, driven by the increasing incidence of snakebites and the rising demand for effective treatments. Snakebites are a global health concern, particularly in regions such as Sub-Saharan Africa, South Asia, and Southeast Asia, where venomous snake populations are prevalent. According to the World Health Organization (WHO), snakebites cause tens of thousands of deaths each year and leave many survivors with long-term disabilities. The growing awareness about the importance of timely and appropriate treatment for snakebites has fueled the demand for anti-venom products. Governments, non-profit organizations, and healthcare providers have been actively working to improve access to anti-venom in high-risk regions. This has resulted in increased production and distribution of anti-venom, thus contributing to market growth. Additionally, advancements in biotechnology and the development of new manufacturing techniques have led to the production of more effective and safer anti-venom products. These advancements have significantly enhanced the treatment outcomes and reduced the risk of adverse reactions associated with older anti-venom formulations. However, the global market still faces several challenges. One of the key challenges is the high cost of anti-venom products, which limits their accessibility, particularly in low-income regions. Many snakebite victims in these areas are unable to afford the treatment, leading to delays or inadequate care. Another challenge is the lack of standardization in anti-venom production and quality control. Different snake species produce different venoms, and the effectiveness of anti-venom can vary depending on the geographical location and the specific venom composition. Standardization of anti-venom production is crucial to ensure consistent quality and efficacy across different products. Moreover, the production of anti-venom is complex and time-consuming. It involves the extraction of venom from live snakes, which requires specialized facilities and expertise. Scaling up production to meet the increasing demand can be challenging, especially for rare or region-specific snake venoms.
US Anti-Venom Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
polyvalent
Fastest Growth
polyvalent
Growth Rate
7.7% CAGR
Global Anti-venom Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Anti-Venom Market Segmental Analysis
Global Anti-Venom Market is segmented on the basis of type, species, and region. By type, the market is segmented into polyvalent anti-venom and monovalent anti-venom. By species, the market is segmented into snakes, scorpions, spiders, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Anti-Venom Market Analysis By Species
The global anti-venom market can be segmented by species, including snakes, scorpions, spiders, and others. Snakes dominate the market due to the high prevalence of snakebites globally. Snakebites pose a significant health risk in various regions, particularly in tropical and subtropical areas, where venomous snake populations are abundant. Therefore, the demand for snake anti-venom remains the highest, making it the dominant segment in the global anti-venom market.
In terms of the fastest-growing segment, scorpion anti-venom is gaining momentum in recent years. Scorpion stings are a growing concern, particularly in regions like North Africa, the Middle East, and parts of South America. Scorpions are found in diverse habitats, including deserts, forests, and urban areas, increasing the risk of encounters with humans. The venom of certain scorpion species can cause severe symptoms and complications. As a result, the demand for scorpion anti-venom has witnessed a significant surge, making it the fastest-growing segment in the global anti-venom market.
Anti-Venom Market Analysis By Type
The global anti-venom market can be segmented by type into polyvalent anti-venom and monovalent anti-venom. Polyvalent anti-venom, also known as poly-specific or poly-antivenom, is designed to neutralize the venoms of multiple species of venomous snakes or other venomous creatures. It is the dominant segment in the global anti-venom market. Polyvalent anti-venom offers broad-spectrum protection against a range of venoms, making it a versatile and widely used option for treating snakebites and other envenomation cases.
On the other hand, the fastest-growing segment in the global anti-venom market is monovalent anti-venom. Monovalent anti-venom is specific to a particular species or type of venomous creature. It is designed to neutralize the venom of a single snake species or a specific venomous creature like scorpions or spiders. This targeted approach ensures highly effective treatment for envenomation caused by a specific venom.
Global Anti-venom Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Anti-Venom Market Regional Insights
North America dominated the global anti-venom market. The region has a well-established healthcare infrastructure, advanced research and development capabilities, and stringent regulatory standards. North America also has a relatively low incidence of snakebites compared to other regions, but it remains a significant market due to its high demand for anti-venom. This demand is driven by factors such as outdoor recreational activities, the presence of venomous snake species, and the need for preparedness in emergency response. The North American market for anti-venom is supported by strong distribution networks, availability of specialized healthcare facilities, and high consumer awareness.
On the other hand, the Asia Pacific region is the fastest-growing segment in the global anti-venom market. This region encompasses diverse landscapes, climates, and a significant population at risk of snakebites. Countries in Southeast Asia, such as India, Bangladesh, Myanmar, and Thailand, have a high incidence of snakebites and a rich diversity of venomous snake species. The rising awareness about snakebite management, improved access to healthcare facilities, and increased government initiatives have contributed to the growth of the anti-venom market in the Asia Pacific region. Additionally, the presence of unique venomous species in countries like China and Australia further drives the demand for anti-venom, making Asia Pacific a rapidly expanding market in the global anti-venom industry.
Global Anti-venom Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Anti-Venom Market Dynamics
Anti-Venom Market Drivers
Increasing incidence of snakebites
- The rising number of snakebite cases worldwide is a significant driver for the anti-venom market. Snakebites are a global health concern, particularly in regions with high snake populations, leading to an increased demand for effective anti-venom treatments.
Growing awareness and initiatives
- Increased awareness about the importance of timely and appropriate snakebite treatment, coupled with government and non-profit initiatives, has improved access to anti-venom in high-risk regions. Efforts to enhance distribution channels and ensure availability of anti-venom are driving market growth.
Anti-Venom Market Restraints
Limited accessibility in remote areas
- In remote or rural areas, access to anti-venom can be limited due to inadequate healthcare infrastructure and logistical challenges. This limitation hampers timely and efficient treatment for snakebite victims in these regions.
Adverse reactions
- While efforts have been made to improve the safety of anti-venom products, there is still a risk of adverse reactions, including allergic reactions and serum sickness. Such adverse events can impact patient acceptance and market growth.
Request Free Customization of this report to help us to meet your business objectives.
Anti-Venom Market Competitive Landscape
The competitive landscape of the global anti-venom market is characterized by a mix of established pharmaceutical companies, biotechnology firms, and regional manufacturers. These industry players are focused on developing and supplying anti-venom products to meet the growing demand for effective snakebite treatments worldwide. The market is driven by intense competition, with companies striving to differentiate their products based on factors such as safety, efficacy, potency, and broad-spectrum coverage. Manufacturers are investing in research and development activities to improve the quality and effectiveness of anti-venom formulations. They are also focusing on optimizing production processes to ensure scalability and cost-efficiency. Collaborations and partnerships are common strategies in the global anti-venom market. Companies often collaborate with research institutions, non-profit organizations, and government bodies to strengthen their product portfolios and expand their geographic reach. These partnerships enable the sharing of expertise, resources, and knowledge, fostering innovation and improved access to anti-venom treatment. Additionally, market players engage in strategic initiatives such as mergers, acquisitions, and licensing agreements to enhance their market presence and expand their product offerings. These actions allow companies to gain access to new technologies, manufacturing capabilities, and distribution networks, further fueling their competitive advantage. Moreover, regulatory compliance plays a crucial role in the anti-venom market, as manufacturers need to adhere to stringent quality standards and safety regulations. Obtaining regulatory approvals and maintaining compliance is essential for market players to ensure the safety and efficacy of their anti-venom products.
Anti-Venom Market Top Player’s Company Profiles
- Bharat Serums and Vaccines Ltd. - India
- Sanofi Pasteur SA - France
- Instituto Bioclon - Mexico
- Haffkine Bio-Pharmaceutical Corporation Ltd. - India
- Rare Disease Therapeutics, Inc. - US
- Incepta Pharmaceuticals Ltd. - Bangladesh
- VINS Bioproducts Limited - India
- MicroPharm Limited - UK
- Taj Pharmaceuticals Limited - India
- Protherics PLC - UK
- Instituto Clodomiro Picado - Costa Rica
- Laboratorios Silanes S.A. - Mexico
- Veninov - France
- JBCPL - India
- Bioclon Institute - Mexico
- Rare Therapeutics - US
- MicroPharm Asia Pacific - Australia
Anti-Venom Market Recent Developments
- In March 2022, Brazilian pharmaceutical company Butantan Institute announced the launch of its new polyvalent antivenom for the treatment of snake bites in Brazil.
- In May 2022, US-based biotech company Agenus Inc. announced the completion of a Phase 2 clinical trial of its new antivenom for the treatment of snake bites in the United States.
Anti-Venom Key Market Trends
- Awareness and education campaigns: Awareness campaigns and educational initiatives aimed at healthcare professionals, communities, and individuals are on the rise. These efforts aim to enhance knowledge about snakebite prevention, early recognition, and appropriate treatment, thereby reducing mortality and morbidity associated with snakebites.
- Rising use of biotechnology: Biotechnology plays a significant role in the development of anti-venom products. Advancements in biotechnology, such as the use of recombinant DNA technology and antibody engineering, are being explored to improve the production process, increase product efficacy, and reduce adverse reactions.
Anti-Venom Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global anti-venom market analysis, the market is a vital sector within the pharmaceutical and biotechnology industries, driven by the need for effective treatments for snakebites and envenomation cases worldwide. The market is characterized by a competitive landscape with a diverse range of companies, including established pharmaceutical giants, regional manufacturers, and biotechnology firms. Key drivers of the market include the increasing incidence of snakebites, growing awareness about snakebite management, technological advancements in venom identification and production processes, and ongoing research and development activities. These drivers contribute to the demand for anti-venom products and stimulate market growth. However, the market also faces challenges such as high costs associated with anti-venom, lack of standardization, limited accessibility in remote areas, and the risk of adverse reactions. These factors can hinder the availability and affordability of anti-venom treatments, particularly in resource-constrained regions. To address these challenges, companies in the market are focusing on collaborations, partnerships, and research initiatives to enhance product quality, expand geographic reach, and improve access to anti-venom treatments. Additionally, governments and healthcare organizations are implementing initiatives to raise awareness, strengthen healthcare infrastructure, and ensure affordable pricing of anti-venom.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 317.50 million |
| Market size value in 2031 | USD 619 million |
| Growth Rate | 7.7% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Anti-Venom Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Anti-Venom Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Anti-Venom Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Anti-Venom Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Anti-Venom Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Anti-Venom Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
